EudraGMP Homepage      
 
 
MIA | GMP | API REG | WDA | GDP | Sites Help
Tue 10 Nov 2026 14:31:06 BST
GMP Compliance Menu 
Search
GMP Certificates
Non-Compliance Report
  
The Certificate has been withdrawn, withdrawn date is : 2024-07-18


Print Preview
                  
Print Preview (Short version)
                  
Back To Search

 

Health Products Regulatory Authority

CERTIFICATE NUMBER: 32527/M00807/00002

CERTIFICATE OF GMP COMPLIANCE OF A MANUFACTURER

Part 1

The competent authority of IRELAND confirms the following:

The manufacturer: Takeda Ireland Limited

Site address: Grange Castle Business Park, Nangor Road, Dublin 22, D22 XR57, Ireland

OMS Organisation Id. / OMS Location Id.: ORG-100011801 / LOC-100020884

 DUNS Number: 98-568-0623

Has been inspected under the national inspection programme in connection with manufacturing authorisation no.  M00807/00002  in accordance with Art. 40 of Directive 2001/83/EC, transposed in the following national legislation:Medicinal Products (Control of Manufacture) Regulations 2007 (S.I. No. 539/2007), as amended..


From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on  2023-07-14 , it is considered that it complies with:


 The authenticity of this certificate may be verified in EudraGMDP. If it does not appear, please contact the issuing authority.


Part 2

Human Medicinal Products

1  MANUFACTURING OPERATIONS
1.1  Sterile products
   1.1.1  Aseptically prepared (processing operations for the following dosage forms)
           1.1.1.4  Small volume liquids
   1.1.3  Batch certification
1.2  Non-sterile products
   1.2.1  Non-sterile products (processing operations for the following dosage forms)
           1.2.1.1  Capsules, hard shell
           1.2.1.17  Other: Other non-sterile medicinal product-Manufacture of intermediates (powders for further processing)(en)
   1.2.2  Batch certification
1.3  Biological medicinal products (list of product types)
   1.3.1  Biological medicinal products (list of product types)
           1.3.1.3  Cell therapy products
   1.3.2  Batch Certification (list of product types)
           1.3.2.3  Cell therapy products
1.5  Packaging
   1.5.1  Primary Packaging
           1.5.1.1  Capsules, hard shell
   1.5.2  Secondary packaging
1.6  Quality control testing
   1.6.1  Microbiological: sterility
   1.6.2  Microbiological: non-sterility
   1.6.3  Chemical/Physical
   1.6.4  Biological

2  IMPORTATION OF MEDICINAL PRODUCTS
2.1  Quality control testing of imported medicinal products
   2.1.2  Microbiological: non-sterility
   2.1.3  Chemical/Physical
2.2  Batch certification of imported medicinal products
   2.2.2  Non-sterile products
2.3  Other importation activities
   2.3.1  Site of physical importation

Clarifying remarks (for public users):
1.3.1.3 relates to Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue. This section also applies to manufacture of the biological active substance. The manufacture of sterile products(1.1), biological medicinal products (1.3), microbiological sterility testing 1.6.1 and biological testing 1.6.4 were not included within the scope of inspection 33754. 1.2.1.1 & 1.5.1.1 relate to a highly potent product manufactured and primary packaged in a dedicated facility. Authorised operations include remote batch certification by Qualified Person when operating within EEA or Northern Ireland. The HPRA does not routinely issue hard copies of GMP certificates. Authenticity of GMP certification may be verified on the EudraGMDP database.

 

 


Withdrawal comments in English: New one uploaded


 
 
 
     
 
 
 
 
The EudraGMDP database is maintained and operated by the EMA. Access to the general public is granted in order to enhance availability of information related to the EMA mandate. The content of the database is provided by the National Competent Authorities (NCA) of the EEA. For this reason, the EMA accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage it might occur to you and/or any other third party) arising out of or in connection with the information on this database. Any questions about the content should be addressed to the relevant NCA. Please click here to get list of NCA's.

For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI.

Documents issued by UK authorities up to and including 31 December 2020 remain available for consultation in EudraGMDP. However, they are no longer included or updated from 1 January 2021, with the exception of the documents pertaining to sites located in Northern Ireland.

[EMA © 2014. EudraGMDP 6.5.4.8 build 2026/01/16 09:45]